Dietary Treatment Study of Fat Synthesis and Risk of Cardiovascular Disease

Lipogenesis, Lipoprotein Flux, and CVD Risk: Role of Meal Composition and Frequency

The purpose of this study is to find out how the amount of fat or sugar in a person's diet, or the number of meals eaten each day, affect the amount of fat that people's bodies make, the types of fats in the bloodstream, and how much fat is stored in the liver. The study is funded by the National Institutes of Health.

Study Overview

Detailed Description

The study consists of two 10-day feeding periods that are separated by approximately two weeks. During each feeding period all food and beverages to be consumed will be provided by the study.

In Study 1, participants will be randomly assigned to receive one of two diets. Both diets are designed to maintain weight at a constant level. The diets are balanced nutritionally and have the same amount of protein. One diet has higher amounts of sugar, while the other has higher amounts of fat. For one 10-day period, the diet will be fed as two large meals ('meal-feeding'). For the other 10-day period, the identical diet will be fed as 8 small meals ('nibbling'). Half of the participants will meal-feed first, while the other half will 'nibble' first. The order of nibbling or meal feeding will be determined randomly.

In Study 2, the number of meals eaten per day will remain fixed at three (no nibbling or meal feeding). Participants will receive both the diet higher in sugar and the diet higher in fat. However, they will be randomly assigned to start one followed by the other for each 10-day feeding period.

At the end of each 10-day feeding period, participants will spend two nights in a research ward (Clinical Research Center) to undergo testing.

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94110
        • University of California, San Franciso, San Francisco General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • overweight or obese men and women
  • ages 20-65 years

Exclusion Criteria:

  • pregnancy or lactation within the past six months
  • type 1 or 2 diabetes mellitus]
  • AST and ALT above upper limit of normal (ULN)
  • fasting triglyceride or total cholesterol levels >ULN
  • Hgb below the lower of limit of normal
  • positive HIV antibody test or hepatitis serologies
  • use of any antidiabetic medications or lipid-lowering drugs
  • history of surgery for obesity
  • change in body weight >5% within preceding 6 months (self report)
  • claustrophobia, presence of metal implants
  • weight over 350 lbs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: High sugar/meal feed
Diet high in simple sugar fed as two large meals daily
Weight-maintaining diet relatively high in sugar fed as two large meals daily
Weight-maintaining diet relatively high in sugar fed as 8 meals daily
EXPERIMENTAL: High sugar/nibble
Diet high in simple sugar fed as 8 small meals daily
Weight-maintaining diet relatively high in sugar fed as two large meals daily
Weight-maintaining diet relatively high in sugar fed as 8 meals daily
EXPERIMENTAL: High fat/meal feed
Diet high in fat fed as two large meals daily
Weight-maintaining diet relatively high in fat fed as two large meals daily
Weight-maintaining diet relatively high in fat fed as 8 small meals daily
EXPERIMENTAL: High fat/nibble
Diet high in fat fed as 8 small meals daily
Weight-maintaining diet relatively high in fat fed as 8 small meals daily
EXPERIMENTAL: High sugar/3 meals a day
Diet high in simple sugar fed as 3 meals a day
Weight-maintaining diet relatively high in sugar fed as 3 meals daily
Weight-maintaining diet relatively high in fat fed as 3 meals daily
EXPERIMENTAL: High fat/ 3 meals a day
Diet high in fat fed as 3 meals a day
Weight-maintaining diet relatively high in sugar fed as 3 meals daily
Weight-maintaining diet relatively high in fat fed as 3 meals daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of meal composition on fractional de novo lipogenesis (fatty acid synthesis)
Time Frame: After 10-day dietary period

Differences between high carbohydrate and high fat diets on postprandial de novo lipogenesis

De novo lipogenesis will be measured using stable (not radioactive) isotopes given intravenously and orally during feeding.

After 10-day dietary period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of meal frequency on fractional de novo lipogenesis (fatty acid synthesis)
Time Frame: After 10-day dietary period

Differences between consuming the same diet as eight small meals per day or two larger meals per day on postprandial de novo lipogenesis.

Please see description of measurement of de novo lipogenesis under aim 1.

After 10-day dietary period

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Liver fat content
Time Frame: After 10-day dietary period

Effects of diet composition or meal frequency on fat stored in the liver.

Liver fat content will be measured non-invasively using magnetic resonance spectroscopy.

After 10-day dietary period
Lipids and lipoproteins in the blood
Time Frame: After 10-day dietary intervention period

Effects of diet composition or meal frequency on the types of fats in the bloodstream that might affect risk of heart disease.

The types of fats in the bloodstream will be measured in blood samples collected while the participant is fasting and also during the stable isotope/feeding study of de novo lipogenesis.

After 10-day dietary intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Marc Schwarz, PhD, Touro University, California

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (ANTICIPATED)

December 1, 2022

Study Completion (ANTICIPATED)

December 1, 2022

Study Registration Dates

First Submitted

February 26, 2014

First Submitted That Met QC Criteria

February 27, 2014

First Posted (ESTIMATE)

March 3, 2014

Study Record Updates

Last Update Posted (ACTUAL)

May 19, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Nibble99

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on High sugar/meal feed

3
Subscribe